Cargando…

The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials

The phosphaturic hormone fibroblast growth factor 23 (FGF23) is a risk marker of cardiovascular and all-cause mortality. We therefore aimed to synthesize the evidence for the effect of vitamin D administration on circulating FGF23 concentrations. We performed a systematic review and meta-analysis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zittermann, Armin, Berthold, Heiner K., Pilz, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510890/ https://www.ncbi.nlm.nih.gov/pubmed/32855522 http://dx.doi.org/10.1038/s41430-020-00725-0

Ejemplares similares

Correction: The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2021)

Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2023)

A 3 year post‐intervention follow‐up on mortality in advanced heart failure (EVITA vitamin D supplementation trial)
por: Zittermann, Armin, et al.
Publicado: (2020)

Reply to Meshkini et al.
por: Zittermann, Armin, et al.
Publicado: (2021)

Effects of vitamin D supplementation on FGF23: a randomized-controlled trial
por: Trummer, Christian, et al.
Publicado: (2018)

Vitamin D and airway infections: a European perspective
por: Zittermann, Armin, et al.
Publicado: (2016)

Effects of Vitamin D Supplementation on Renin and Aldosterone Concentrations in Patients with Advanced Heart Failure: The EVITA Trial
por: Zittermann, Armin, et al.
Publicado: (2018)

Critical Appraisal of Large Vitamin D Randomized Controlled Trials
por: Pilz, Stefan, et al.
Publicado: (2022)

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial
por: Ernst, Jana B., et al.
Publicado: (2016)

Vitamin D and Cardiovascular Disease: An Updated Narrative Review
por: Zittermann, Armin, et al.
Publicado: (2021)

Effects of Vitamin D Supplementation on 24-Hour Blood Pressure in Patients with Low 25-Hydroxyvitamin D Levels: A Randomized Controlled Trial
por: Theiler-Schwetz, Verena, et al.
Publicado: (2022)

Randomized supplementation of 4000 IU vitamin D(3) daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial
por: Ernst, J. B., et al.
Publicado: (2017)

The Biphasic Effect of Vitamin D on the Musculoskeletal and Cardiovascular System
por: Zittermann, Armin
Publicado: (2017)

Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial
por: Schwetz, Verena, et al.
Publicado: (2017)

Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial
por: Trummer, Christian, et al.
Publicado: (2017)

Nonclassical Vitamin D Action
por: Zittermann, Armin, et al.
Publicado: (2010)

Magnesium deficit ? overlooked cause of low vitamin D status?
por: Zittermann, Armin
Publicado: (2013)

Vitamin D testing and treatment: a narrative review of current evidence
por: Pilz, Stefan, et al.
Publicado: (2019)

The Role of Vitamin D in Fertility and during Pregnancy and Lactation: A Review of Clinical Data
por: Pilz, Stefan, et al.
Publicado: (2018)

The Gut Microbiota Regulates Endocrine Vitamin D Metabolism through Fibroblast Growth Factor 23
por: Bora, Stephanie A., et al.
Publicado: (2018)

A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program
por: Frisch, Sabine, et al.
Publicado: (2009)

Vitamin D, Fibroblast Growth Factor 23 and Incident Cognitive Impairment: Findings from the REGARDS Study
por: Panwar, Bhupesh, et al.
Publicado: (2016)

Klotho and Fibroblast Growth Factor 23 Are Independent of Vitamin D, and Unlike Vitamin D, Are Not Associated With Graft- and Patient Survival After Kidney Transplantation
por: Thorsen, Inga Strand, et al.
Publicado: (2023)

Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease
por: Hu, Peng, et al.
Publicado: (2012)

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
por: Roberts, Matthew A., et al.
Publicado: (2016)

Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases—An Umbrella Review
por: Maretzke, Friederike, et al.
Publicado: (2020)

Effects of Single Vitamin D(3) Injection (200,000 Units) on Serum Fibroblast Growth Factor 23 and Sclerostin Levels in Subjects with Vitamin D Deficiency
por: Zhang, Dongdong, et al.
Publicado: (2017)

Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D
por: Grant, William B., et al.
Publicado: (2022)

25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population
por: Jovanovich, Anna J., et al.
Publicado: (2014)

Effect of Two Different Multimicronutrient Supplements on Vitamin D Status in Women of Childbearing Age: A Randomized Trial
por: Pilz, Stefan, et al.
Publicado: (2017)

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: a Mendelian Randomization study
por: Donovan, Killian, et al.
Publicado: (2023)

Effects of Vitamin D Supplementation on Body Composition and Metabolic Risk Factors in Men: A Randomized Controlled Trial
por: Lerchbaum, Elisabeth, et al.
Publicado: (2019)

Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
por: Bleskestad, Inger H, et al.
Publicado: (2012)

Vitamin D, PCOS and androgens in men: a systematic review
por: Trummer, Christian, et al.
Publicado: (2018)

Fibroblast growth factor 23 and bone mineralisation
por: Guo, Yu-Chen, et al.
Publicado: (2015)

Physiological Actions of Fibroblast Growth Factor-23
por: Erben, Reinhold G.
Publicado: (2018)

Upstream Regulators of Fibroblast Growth Factor 23
por: Ratsma, Danielle M. A., et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Independent Association of Circulating Vitamin D Metabolites with Anemia Risk in Patients Scheduled for Cardiac Surgery
por: Ernst, Jana B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ihfradlvlfhjkj1up40g6k4smp